Approval · Notice of Compliance 4156 · 1997
TOPAMAX: Notice of Compliance 4156
Issued May 29, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4156
- Date
- May 29, 1997
- Company
- Ortho Pharmaceutical, Division Of Janssen-Ortho Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- To facilitate dosage adjustment
- Therapeutic class
- Anti-epileptic
Products in this notice
Medicinal ingredients
- TOPIRAMATE 50 MG per TAB
- TOPIRAMATE 300 MG per TAB
- TOPIRAMATE 400 MG per TAB